Elanco Animal Health Incorporated (ELAN)
| Market Cap | 6.03B |
| Revenue (ttm) | 4.65B |
| Net Income (ttm) | -175.00M |
| Shares Out | 468.45M |
| EPS (ttm) | -0.75 |
| PE Ratio | n/a |
| Forward PE | 9.47 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,137,679 |
| Open | 12.77 |
| Previous Close | 12.56 |
| Day's Range | 12.59 - 13.17 |
| 52-Week Range | 12.19 - 35.00 |
| Beta | 0.87 |
| Analysts | Buy |
| Price Target | 21.68 (+68.5%) |
| Earnings Date | Nov 3, 2022 |
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticid... [Read more...]
Financial Performance
In 2021, ELAN's revenue was $4.77 billion, an increase of 45.59% compared to the previous year's $3.27 billion. Losses were -$472.00 million, -15.71% less than in 2020.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for ELAN stock is "Buy." The 12-month stock price forecast is 21.68, which is an increase of 68.45% from the latest price.
News
Elanco Announces Changes to its Board of Directors
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Scott Ferguson, founder and managing partner of Sachem Head Capital Management LP (“Sachem Head”), ...
5 Pet Care Stocks Gurus Love
Despite inflationary pressures that are increasing the price of goods across the board, consumers are still pampering their pets when it comes to food.
Elanco to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022. Jeff Simmons, pre...
Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ Goals
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE:ELAN) today released its 2021 Environmental, Social and Governance (ESG) Report “Changing The World One Animal at a Time” highl...
Elanco Animal Health Incorporated (ELAN) Tops Q2 Earnings Estimates
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 38.46% and 0.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the...
Elanco Animal Health Reports Second Quarter 2022 Results
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the second quarter of 2022, provided guidance for the third quarter of 2022, and up...
Got $5,000? These 2 Beaten-Down Growth Stocks Are Great Buys Right Now
Shares of these two companies are down more than 20% this year, providing a potential opportunity for investors.
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2022 financial results on Monday, August 8, 2022. Elanco will also conduct a conference...
Elanco Survey Finds Many Pets Live Unprotected Against Preventable Diseases
GREENFIELD, Ind.--(BUSINESS WIRE)--Amidst a surge of pet adoptions, a new survey released by Elanco finds many pets are insufficiently protected against common diseases like Lyme and leptospirosis. Once...
What's Next For Elanco Stock After A 17% Fall In A Month?
Elanco (NASDAQ: ELAN), an animal health products company, has seen a 17% fall in a month, underperforming the broader S&P500, which is down 9%.
The 3 Best Pet Stocks to Buy Now
Pets are a big part of the family in America and that trend is only growing. Here are some top pet stocks to help you profit from the trend.
Got $5,000? Here Are 2 Top Growth Stocks to Buy for July
These stocks are relatively cheap and have a boatload of potential.
New Anthem from Seresto Could be the 2022 Song of the Summer
GREENFIELD, Ind.--(BUSINESS WIRE)--Each long-awaited summer brings a new, upbeat anthem for blaring with the car windows down or tapping your paws on the trail. This summer's anthem is for the dogs and ...
Elanco to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 43rd Annual Global Healthcare Conference, June 13-14, 2022. Todd Young, executive vice pre...
Elanco to Participate in Stifel 2022 Jaws and Paws Conference
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Stifel 2022 Jaws and Paws Conference on Wednesday, June 1, 2022. Jeff Simmons, president and CEO, will p...
Vanguard Health Care Fund's Top 5 Trades in the 1st Quarter
The Vanguard Health Care Fund (Trades, Portfolio) recently disclosed its first quarter 2022 portfolio, revealing that its top five trades for the quarter included a new position in Zoetis Inc. ( ZTS , F...
Elanco Animal Health Cuts FY22 Guidance After Q1 Earnings Beat Expectations Marginally
Elanco Animal Health Inc (NYSE: ELAN) has reported a Q1 EPS of $0.36, lower than the $0.37 reported a year ago, surpassing analysts' view of $0.35. Revenue was $1.225 billion, a decrease of 1% YY, sligh...
Elanco Animal Health Incorporated (ELAN) Surpasses Q1 Earnings and Revenue Estimates
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 2.86% and 0.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the...
Elanco Animal Health Reports First Quarter 2022 Results
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the first quarter of 2022, provided guidance for the second quarter of 2022, and up...
Is a Surprise Coming for Elanco (ELAN) This Earnings Season?
Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1
Improved patient volumes, a diversified healthcare portfolio and various technological advancements are likely to favor first-quarter results of ELAN, DCGO and OMIC.
Why Elanco Animal Health Incorporated (ELAN) Could Beat Earnings Estimates Again
Elanco Animal Health Incorporated (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Product...
GREENFIELD, Ind. & HEERLEN, Netherlands--(BUSINESS WIRE)--Elanco Animal Health Incorporated (ELAN: NYSE) and Royal DSM have created a strategic alliance connecting two leading, sustainability-focused co...
Elanco Confirms Date and Conference Call for First Quarter 2022 Financial Results Announcement
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2022 financial results on Monday, May 9, 2022. Elanco will also conduct a conference cal...